Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5

Virology
Pengjuan GongJingmin Gu

Abstract

Due to the worldwide prevalence of antibiotic resistant strains, phages therapy has been revitalized recently. In this study, an Enterococcus faecium phage named IME-EFm5 was isolated from hospital sewage. Whole genomic sequence analysis demonstrated that IME-EFm5 belong to the Siphoviridae family, and has a double-stranded genome of 42,265bp (with a 35.51% G+C content) which contains 70 putative coding sequences. LysEFm5, the endolysin of IME-EFm5, contains an amidase domain in its N-terminal and has a wider bactericidal spectrum than its parental phage IME-EFm5, including 7 strains of vancomycin-resistant E. faecium. The mutagenesis analysis revealed that the zinc ion binding residues (H27, H132, and C140), E90, and T138 are required for the catalysis of LysEFm5. However, the antibacterial activity of LysEFm5 is zinc ion independent, which is inconsistent with most of other amidase members. The phage lysin LysEFm5 might be an alternative treatment strategy for infections caused by multidrug-resistant E. faecium.

References

Jun 1, 1994·The Journal of Antimicrobial Chemotherapy·A P Johnson
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Jun 11, 1998·Emerging Infectious Diseases·M M HuyckeM S Gilmore
Sep 2, 1999·Critical Care Medicine·J D EdgeworthS J Eykyn
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·A SulakvelidzeJ G Morris
Sep 7, 2001·Annual Review of Microbiology·W C Summers
Apr 20, 2005·Journal of Applied Microbiology·B MartinT Aymerich
Apr 7, 2006·Applied and Environmental Microbiology·David M DonovanDavid G Pritchard
Nov 21, 2007·PLoS Pathogens·Angela B BrueggemannBernard Beall
Apr 16, 2008·Nucleic Acids Research·Jason R Grant, Paul Stothard
Oct 11, 2008·Bioinformatics·Tim CarverMarie-Adèle Rajandream
Feb 6, 2010·Journal of Applied Microbiology·B A LaytonA B Boehm
Mar 20, 2010·PLoS Pathogens·Sebastian ZollThilo Stehle
May 12, 2010·Nucleic Acids Research·Liisa Holm, Päivi Rosenström
Nov 26, 2010·Applied and Environmental Microbiology·Jumpei UchiyamaMasanori Daibata
Jan 6, 2012·Archives of Virology·Jumpei UchiyamaMasanori Daibata
May 25, 2013·Future Microbiology·Benjamin K ChanCatherine Loc-Carrillo
Jan 18, 2015·Applied and Environmental Microbiology·Minsuk Kong, Sangryeol Ryu
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Mathias SchmelcherDavid M Donovan
Feb 25, 2015·Trends in Microbiology·Franklin L NobregaJoana Azeredo
Mar 4, 2015·The Journal of Antimicrobial Chemotherapy·Roberto Díez-MartínezPedro García
Apr 22, 2015·Applied Microbiology and Biotechnology·Mathias SchmelcherDavid M Donovan
Aug 10, 2015·Research in Microbiology·Mei YangWenyu Han
Sep 16, 2015·Antimicrobial Agents and Chemotherapy·Chunhui ChenMinggui Wang

❮ Previous
Next ❯

Citations

Nov 9, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Norival A Santos-FilhoEduardo M Cilli
Jan 24, 2019·IUBMB Life·Dibya Saha, Raju Mukherjee
Dec 8, 2019·Applied and Environmental Microbiology·Tsvetelina H BaryakovaBenjamin J Hackel
Jan 13, 2019·Viruses·Julien LossouarnMarie-Agnès Petit
Apr 17, 2019·Frontiers in Microbiology·Mansura S MulaniKarishma R Pardesi
Jun 16, 2017·Annual Review of Microbiology·Brittany B Lewis, Eric G Pamer
Dec 3, 2020·Expert Review of Anti-infective Therapy·Amrita PatilSunil Saroj
May 4, 2021·Comprehensive Reviews in Food Science and Food Safety·Zhenhua HuangYong Zhao
Jun 9, 2021·Future Microbiology·Zhen ChenYuqin Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.